Clinical Trials
10
Trial Phases
3 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (10 trials with phase data)β’ Click on a phase to view related trials
A Study of Gemcitabine Β± Erlotinib and DN-101 Versus Gemcitabine Β± Erlotinib and Placebo in Patients With Advanced Pancreatic Cancer
- Conditions
- Pancreatic Cancer
- Interventions
- First Posted Date
- 2007-09-28
- Last Posted Date
- 2007-11-06
- Lead Sponsor
- Novacea
- Target Recruit Count
- 132
- Registration Number
- NCT00536770
- Locations
- πΊπΈ
Novacea Investigational Site, Nashville, Tennessee, United States
AQ4N in Combination With Radiotherapy and Temozolomide in Subjects With Newly Diagnosed Glioblastoma Multiforme
- Conditions
- Glioblastoma Multiforme
- First Posted Date
- 2006-11-01
- Last Posted Date
- 2007-05-30
- Lead Sponsor
- Novacea
- Target Recruit Count
- 60
- Registration Number
- NCT00394628
- Locations
- πΊπΈ
University of California, Los Angeles, Los Angeles, California, United States
πΊπΈNorthwestern University Feinberg School of Medicine, Chicago, Illinois, United States
πΊπΈHenry Ford Health Systems, Detroit, Michigan, United States
Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004
- Conditions
- Androgen Independent Prostate Cancer (AIPC)Non Small Cell Lung Cancer (NSCLC)
- First Posted Date
- 2006-02-02
- Last Posted Date
- 2006-05-31
- Lead Sponsor
- Novacea
- Target Recruit Count
- 25
- Registration Number
- NCT00285675
- Locations
- πΊπΈ
Alta Bates Comprehensive Cancer Center, Berkeley, California, United States
πΊπΈPacific Hematology Oncology Associates, San Francisco, California, United States
πΊπΈKaiser Permanente Medical Group, Northern California, Vallejo, California, United States
DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2])
- Conditions
- Prostate Cancer
- First Posted Date
- 2006-01-09
- Last Posted Date
- 2007-11-06
- Lead Sponsor
- Novacea
- Target Recruit Count
- 1200
- Registration Number
- NCT00273338
- Locations
- πΊπΈ
Birmingham Hematology & Oncology Associates, LLC, Birmingham, Alabama, United States
πΊπΈNorthwest Alabama Cancer Center, Muscle Shoals, Alabama, United States
πΊπΈAlaska Clinical Research Center, Anchorage, Alaska, United States
Study of AQ4N in Patients With Non Hodgkin's Lymphoma, Chronic Lymphocytic Leukemia, or Small Lymphocytic Leukemia
- Conditions
- Non-Hodgkin's LymphomaChronic Lymphocytic LeukemiaSmall Lymphocytic Leukemia
- First Posted Date
- 2005-04-27
- Last Posted Date
- 2007-05-07
- Lead Sponsor
- Novacea
- Target Recruit Count
- 55
- Registration Number
- NCT00109356
- Locations
- πΊπΈ
Weill Medical College of Cornell University/ New York Presbyterian Hospital, New York, New York, United States
- Prev
- 1
- 2
- Next